The Beta-2 Glycoprotein 1 Panel (IgG, IgM, IgA) is used to help diagnose Antiphospholipid Syndrome (APS), a condition that increases the risk of blood clotting. It is particularly useful in the following situations:
This test measures specific antibodies (IgG, IgM, IgA) against Beta-2 Glycoprotein 1, which can help guide diagnosis and treatment for managing clotting risks, particularly in individuals with a history of blood clots or recurrent miscarriages.